Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3859856, 14 pages
https://doi.org/10.1155/2017/3859856
Research Article

Cynanchum wilfordii Polysaccharides Suppress Dextran Sulfate Sodium-Induced Acute Colitis in Mice and the Production of Inflammatory Mediators from Macrophages

1Traditional Food Research Center, Korea Food Research Institute, Seongnam, Gyeonggi 13539, Republic of Korea
2Department of Oriental Medicinal Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, Gyeonggi 17104, Republic of Korea

Correspondence should be addressed to Mi Jang; rk.er.irfk@imgnaj

Received 1 February 2017; Revised 28 April 2017; Accepted 4 May 2017; Published 20 June 2017

Academic Editor: Dezheng Zhao

Copyright © 2017 Chang-Won Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Hui and A. Zumla, “Advancing priority research on the Middle East respiratory syndrome coronavirus,” The Journal of Infectious Diseases, vol. 209, no. 2, pp. 173–176, 2014. View at Google Scholar
  2. D. Loomis, Y. Grosse, B. Lauby-Secretan et al., “The carcinogenicity of outdoor air pollution,” The Lancet Oncology, vol. 14, no. 13, pp. 1262-1263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Head and J. S. Jurenka, “Inflammatory bowel disease part 1: ulcerative colitis—pathophysiology and conventional and alternative treatment options,” Alternative Medicine Review, vol. 8, no. 3, pp. 247–283, 2003. View at Google Scholar
  4. P. Munkholm, E. Langholz, D. Hollander et al., “Intestinal permeability in patients with Crohn’s disease and ulcerative colitis and their first degree relatives,” Gut, vol. 35, no. 1, pp. 68–72, 1994. View at Publisher · View at Google Scholar
  5. S. C. Truelove, A. R. Horler, and W. Richards, “Serial biopsy in ulcerative colitis,” British Medical Journal, vol. 2, no. 4956, pp. 1590–1593, 1955. View at Google Scholar
  6. L. M. Lix, L. A. Graff, J. R. Walker et al., “Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 14, no. 11, pp. 1575–1584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Opheim, T. Bernklev, M. S. Fagermoen, M. Cvancarova, and B. Moum, “Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway,” Scandinavian Journal of Gastroenterology, vol. 47, no. 12, pp. 1436–1447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Oxelmark, A. Lindberg, R. Löfberg et al., “Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 11, pp. 1320–1328, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Rawsthorne, I. Clara, L. A. Graff et al., “The Manitoba inflammatory bowel disease cohort study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products,” Gut, vol. 61, no. 4, pp. 521–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. V. Weizman, E. Ahn, R. Thanabalan et al., “Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease,” Alimentary Pharmacology & Therapeutics, vol. 35, no. 3, pp. 342–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tsiang and P. T. Li, “Asclepiadaceae,” in Delectis Florae Reipublicae Popularis Sinicae Agendae Academiae Sinicae, vol. 63 of Flora Reiplicae Popularis Sinicae, pp. 249–575, Science Press, Beijing, 1977, (in Chinese). View at Google Scholar
  12. A. Chang, B. Y. Kwak, K. Yi, and J. S. Kim, “The effect of herbal extract (EstroG-100) on pre-, peri- and post-menopausal women: a randomized double-blind, placebo-controlled study,” Phytotherapy Rresearch, vol. 26, no. 4, pp. 510–516, 2012. View at Google Scholar
  13. M. H. Zenk, H. el-Shagi, and U. Schulte, “Anthraquinone production by cell suspension cultures of Morinda citrifolia,” Planta Medica, vol. 28, pp. 79–101, 1975. View at Publisher · View at Google Scholar
  14. X. Zhang, L. Shan, H. Huang et al., “Rapid identification of acetophenones in two Cynanchum species using liquid chromatography-electrospray ionization tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 3, pp. 715–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Korea Food and Drug Administration (KFDA), July 2016, http://www.mfds.go.kr/herbmed/index.do?nMenuCode=7&code=KHP-N126&includeUrl=/herbmed/view.jsp/.
  16. D. H. Choi, Y. J. Lee, H. C. Oh et al., “Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E(−/−) mice fed a high fat/cholesterol diet,” Journal of Medicinal Food, vol. 15, no. 2, pp. 169–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Y. Hwang, S. E. Kim, Y. H. Kim et al., “Pregnane glycoside multidrug-resistance modulators from Cynanchum wilfordii,” Journal of Natural Products, vol. 62, no. 4, pp. 640–643, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. H. S. Kim, “Effects of Cynanchum wilfordii extract on serum lipid components and enzyme activities in hyperlipidemic and streptozotocin-induced diabetic rats,” Korean Journal of Human Ecology, vol. 7, no. 2, pp. 1–11, 2004. View at Google Scholar
  19. J. Z. Niu, B. K. Ye, and D. F. Wang, “Observation of the protection effect of Baishouwu to the liver of the high serum cholesterol mouse,” Ji Sheng Chong Yu Yi Xue kun Chong Xue Bao, vol. 3, pp. 266–268, 1998. View at Google Scholar
  20. L. Shan, R. H. Liu, Y. H. Shen et al., “Gastroprotective effect of a traditional Chinese herbal drug “baishouwu” on experimental gastric lesions in rats,” Journal of Ethnopharmacology, vol. 107, no. 3, pp. 389–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Shan, W. D. Zhang, C. Zhang, R. H. Liu, J. Su, and Y. Zhou, “Antitumor activity of crude extract and fractions from root tuber of Cynanchum auriculatum Royle ex Wight,” Phytotherapy Research, vol. 19, no. 3, pp. 259–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Y. Yoon, N. H. Choi, B. S. Min et al., “Potent in vivo antifungal activity against powdery mildews of pregnane glycosides from the roots of Cynanchum wilfordii,” Journal of Agricultural and Food Chemistry, vol. 59, no. 22, pp. 12210–12216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Srivastava and D. K. Kulshreshtha, “Bioactive polysaccharides from plants,” Phytochemistry, vol. 28, pp. 2877–2883, 1989. View at Publisher · View at Google Scholar · View at Scopus
  24. L. You, Q. Gao, M. Feng et al., “Structural characterisation of polysaccharides from Tricholoma matsutake and their antioxidant and antitumour activities,” Food Chemistry, vol. 138, no. 4, pp. 2242–2249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Jang, T. G. Lim, S. Ahn et al., “Immune-enhancing effects of a high molecular weight fraction of Cynanchum wilfordii Hemsley in macrophages and immunosuppressed mice,” Nutrients, vol. 8, no. 10, p. 600, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Dore, M. G. das C Faustino Alves, L. S. Will et al., “A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects,” Carbohydrate Polymers, vol. vol. 91, no. 1, pp. 467–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. N. Murthy, H. S. Cooper, H. Shim, R. S. Shah, S. A. Ibrahim, and D. J. Sedergran, “Treatment of dextran sulfate sodium induced murine colitis by intracolonic cyclosporine,” Digestive Diseases and Sciences, vol. 38, no. 9, pp. 1722–1734, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Hamamoto, K. Maemura, I. Hirata, M. Murano, S. Sasaki, and K. Katsu, “Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)),” Clinical and Experimental Immunology, vol. 117, no. 3, pp. 462–468, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Sun, X. Zhang, M. Broderick, and H. Fein, “Measurement of nitric oxide production in biological systems by using Griess reaction assay,” Sensors, vol. 3, no. 8, pp. 276–284, 2003. View at Publisher · View at Google Scholar
  30. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Publisher · View at Google Scholar
  31. B. A. Hendrickson, R. Gokhale, and J. H. Cho, “Clinical aspects and pathophysiology of inflammatory bowel disease,” Clinical Microbiology Reviews, vol. 15, no. 1, pp. 79–94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. Kim, J. H. Ko, Y. D. Jeon et al., “Ixeris dentate NAKAI reduces clinical score and HIF-1 expression in experimental colitis in mice,” Evidence-based Complementary and Alternative Medicine, vol. 2013, no. 67, p. 671281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. B. Kurutas, A. Cetinkaya, E. Bulbuloglu, and B. Kantarceken, “Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis,” Mediators of Inflammation, vol. 2005, no. 6, pp. 390–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Egger, M. Bajaj-Elliott, T. T. MacDonald, R. Inglin, V. E. Eysselein, and M. W. Büchler, “Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency,” Digestion, vol. 62, no. 4, pp. 240–248, 2000. View at Publisher · View at Google Scholar
  35. P. Garside, “Cytokines in experimental colitis,” Clinical and Experimental Immunology, vol. 118, no. 3, pp. 337–339, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Ito, M. Shin-Ya, T. Kishida et al., “Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice,” Clinical and Experimental Immunology, vol. 146, no. 2, pp. 330–338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Taghipour, M. Molaei, N. Mosaffa et al., “An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment,” Gastroenterology and Hepatology from bed to Bench, vol. 9, no. 1, pp. 45–52, 2016. View at Google Scholar
  38. S. E. Crowe and M. H. Perdue, “Functional abnormalities in the intestine associated with mucosal mast cell activation,” Regional Immunology, vol. 4, no. 2, pp. 113–117, 1992. View at Google Scholar
  39. C. Cirillo, G. Sarnelli, G. Esposito et al., “Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein,” Neurogastroenterology and Motility, vol. 21, no. 11, pp. 1209–e112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Talero, S. Sánchez-Fidalgo, C. A. de la Lastra, M. Illanes, J. R. Calvo, and V. Motilva, “Acute and chronic responses associated with adrenomedullin administration in experimental colitis,” Peptides, vol. 29, no. 11, pp. 2001–2012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Rosillo, M. Sánchez-Hidalgo, A. Cárdeno et al., “Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats,” Pharmacological Research, vol. 66, no. 3, pp. 235–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Sánchez-Fidalgo, A. Cárdeno, I. Villegas, E. Talero, and C. A. de la Lastra, “Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice,” European Journal of Pharmacology, vol. 633, no. 1-3, pp. 78–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. P. J. Barnes, “Nuclear factor-kappa B,” The International Journal of Biochemistry & Cell Biology, vol. 29, no. 6, pp. 867–870, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Schreiber, S. Nikolaus, and J. Hampe, “Activation of nuclear factor kappa B inflammatory bowel disease,” Gut, vol. 42, no. 4, pp. 477–484, 1998. View at Publisher · View at Google Scholar
  45. A. C. Tinker and A. V. Wallac, “Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?” Current Topics in Medicinal Chemistry, vol. 6, no. 2, pp. 77–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. P. Pelletier, D. Jovanovic, J. C. Fernandes et al., “Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase,” Arthritis and Rheumatism, vol. 41, no. 7, pp. 1275–1286, 1998. View at Publisher · View at Google Scholar
  47. Z. Lohinai, P. Benedek, E. Fehér et al., “Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat,” British Journal of Pharmacology, vol. 123, no. 3, pp. 353–360, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Levy, M. Valtier, C. De Chillou, P. E. Bollaert, D. Cane, and J. P. Mallie, “Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats,” Shock, vol. 11, no. 2, pp. 98–103, 1999. View at Publisher · View at Google Scholar
  49. W. J. Yoon, Y. M. Ham, B. S. Yoo, J. Y. Moon, J. Koh, and C. G. Hyun, “Oenothera laciniata inhibits lipopolysaccharide induced production of nitric oxide, prostaglandin E2, and proinflammatory cytokines in RAW264.7 macrophages,” Journal of Bioscience and Bioengineering, vol. 107, no. 4, pp. 429–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Ibrahim Abdelwahab, W. Syaed Koko, M. Mohamed Elhassan Taha et al., “In vitro and in vivo anti-inflammatory activities of columbin through the inhibition of cycloxygenase-2 and nitric oxide but not the suppression of NF-κB translocation,” European Journal of Pharmacology, vol. 678, no. 1-3, pp. 61–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Zhang and S. Ghosh, “Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors,” Journal of Endotoxin Research, vol. 6, no. 6, pp. 453–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Frankenberger, A. Pforte, T. Sternsdorf, B. Passlick, P. A. Baeuerle, and H. W. Ziegler-Heitbrock, “Constitutive nuclear NF-kappa B in cells of the monocyte lineage,” The Biochemical Journal, vol. 304, pp. 87–94, 1994. View at Publisher · View at Google Scholar
  53. J. M. Müller, H. W. Ziegler-Heitbrock, and P. A. Baeuerle, “Nuclear factor kappa B, a mediator of lipopolysaccharide effects,” Immunobiology, vol. 187, no. 3-5, pp. 233–256, 1993. View at Publisher · View at Google Scholar
  54. W. Vanden Berghe, S. Plaisance, E. Boone et al., “p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor,” The Journal of Biological Chemistry, vol. 273, no. 6, pp. 3285–3290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation,” Mutation Research, vol. 480–481, pp. 243–268, 2001. View at Google Scholar